{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:29:04Z","timestamp":1781130544794,"version":"3.54.1"},"reference-count":25,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T00:00:00Z","timestamp":1555632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["NeuroRehabilitation"],"published-print":{"date-parts":[[2019,4,19]]},"abstract":"<jats:sec specific-use=\"heading-level-1\">\n                    <jats:title>BACKGROUND:<\/jats:title>\n                    <jats:p>Assistive devices enhance independence and quality of life for people living with motor neuron disease (MND), but prescription can be challenging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec specific-use=\"heading-level-2\">\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>Improved prescription of assistive devices, through improved understanding of the relationship between clinical phenotypes, Amyotrophic Lateral Sclerosis Functional Rating Scale \u2013 Revised (ALSFRS-R) functional domain sub-scores and assistive technology required by people living with MND.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec specific-use=\"heading-level-3\">\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>\n                      Prospective, observational\n                      <jats:bold>c<\/jats:bold>\n                      onsecutive-sample study of 269 patients with MND diagnosis. Main outcome measures: MND phenotype, ALSFRS-R scores and assistive technology devices in use.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec specific-use=\"heading-level-4\">\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      A statistically significant difference in total concurrent assistive technology item use was found between phenotypes (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u200a=\u200a0.001), with those with ALS Bulbar onset using the least. There was also a statistically significant difference in assistive technology usage in five of seven assistive technology categories across the clinical phenotypes, namely orthoses (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u200a&lt;\u200a0.000), mobility devices (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u200a&lt;\u200a0.000), transfer devices (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u200a&lt;\u200a0.000), communication devices (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u200a&lt;\u200a0.000), and activities of daily living devices (\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u200a=\u200a0.016). Correlations between ALSFRS-R sub-score items and assistive technology count confirmed the utility of this outcome measure for equipment prescription.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec specific-use=\"heading-level-5\">\n                    <jats:title>CONCLUSIONS:<\/jats:title>\n                    <jats:p>Clinicians need to consider MND phenotype and\/or ALSFRS-R domain sub-score in clinical decision-making regarding assistive technology, as this will determine the pattern of disease and its progression, and hence assistive technology required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3233\/nre-182511","type":"journal-article","created":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T10:51:59Z","timestamp":1555671119000},"page":"303-313","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":14,"title":["Variation in assistive technology use in Motor Neuron Disease according to clinical phenotypes and ALS Functional Rating Scale \u2013 Revised Score: A prospective observational study"],"prefix":"10.1177","volume":"44","author":[{"given":"Karol","family":"Connors","sequence":"first","affiliation":[{"name":"Calvary Health Care Bethlehem, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Mahony","sequence":"additional","affiliation":[{"name":"Calvary Health Care Bethlehem, Melbourne, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prue","family":"Morgan","sequence":"additional","affiliation":[{"name":"Monash University","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2019,4,19]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.3109\/17482960902835970"},{"key":"e_1_3_2_3_1","first-page":"13","article-title":"The ALSFRS-R: A revised ALS functional rating scale that incoorporates assessments of respiratory function","volume":"169","author":"Cedarbaum, J. M.","year":"1999","unstructured":"Cedarbaum,J. M., Stambler,N., Malta,E., Fuller,C., Hilt,D., Thurmond,B., & Nakanishi,A. (1999). The ALSFRS-R: A revised ALS functional rating scale that incoorporates assessments of respiratory function. BPNF ALS Study Group (Phase III) Journal of Neurological Sciences, 169, 13\u201321.","journal-title":"BPNF ALS Study Group (Phase III) Journal of Neurological Sciences"},{"key":"e_1_3_2_4_1","unstructured":"Cohen J. (1988). Statistic power analysis for the behavioural sciences. Hillsdale NJ: Lawrence Erlbaum Associates."},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1080\/17483107.2017.1396623"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/1460-6984.12235"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2014.920031"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.009551611"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.5014\/ajot.55.5.545"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.3109\/21678421.2015.1074703"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.21951"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2017.1392576"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24659"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24202"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmr.2008.04.004"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.5772\/31774"},{"key":"e_1_3_2_17_1","unstructured":"NICE guideline. Motor Neurone disease: assessment and management [NG42] 2016; https:\/\/www.nice.org.uk\/guidance\/ng42"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1080\/21678421.2017.1304558"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/01459740.2015.1035782"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2016-314661"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1080\/17483100600845414"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/17483107.2013.870239"},{"key":"e_1_3_2_23_1","first-page":"315","article-title":"Why people use and don\u2019t use technologies: Introduction to the special issue on assistive technologies for cognition\/cognitive support technologies","volume":"37","author":"Scherer, M.","year":"2015","unstructured":"Scherer,M. & Federici,S. (2015). Why people use and don\u2019t use technologies: Introduction to the special issue on assistive technologies for cognition\/cognitive support technologies. Neuro Rehabilitation, 37, 315\u2013319.","journal-title":"Neuro Rehabilitation"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1080\/17483107.2016.1253939"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-012054"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2009.10.023"}],"container-title":["NeuroRehabilitation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/NRE-182511","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3233\/NRE-182511","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/NRE-182511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T05:51:54Z","timestamp":1777614714000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3233\/NRE-182511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,19]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,4,19]]}},"alternative-id":["10.3233\/NRE-182511"],"URL":"https:\/\/doi.org\/10.3233\/nre-182511","relation":{},"ISSN":["1053-8135","1878-6448"],"issn-type":[{"value":"1053-8135","type":"print"},{"value":"1878-6448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,19]]}}}